<DOC>
	<DOC>NCT01574261</DOC>
	<brief_summary>Polycystic ovary syndrome (PCOS) is associated with an increased cardiovascular risk. The aim of the study was to evaluate long-term effects of inositol on some cardiovascular risk factors in PCOS patients.</brief_summary>
	<brief_title>Could the Therapy With Inositol Affect the Cardiovascular Risk in PCOS Women? Results of a Randomized Clinical Trial</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Inositol</mesh_term>
	<criteria>Polycystic Ovary Syndrome Age &gt;18 and &lt;35 Chronic or acute inflammatory disease, cancer, autoimmune disease, treatment during the last 6 months prior to our evaluation, DM2, hypertension, major surgery in the last 3 months or other hormonal dysfunctions (hypothalamic, pituitary, thyroidal, or adrenal causes).</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Polycystic Ovary Syndrome</keyword>
	<keyword>Cardiovascular risk</keyword>
	<keyword>Metabolic Syndrome</keyword>
</DOC>